Sennazon (sennosides) Syrup, 8.8 mg, 8 fl. oz. (237 mL) bottle, Mfd. for: Bayshore Pharmaceuticals, Tampla, FL 33619, NDC 76518-100-08.
Published October 5, 2016 · Recall initiated: August 8, 2016
Summary
FDA records drug Class II recall D-1520-2016, published October 5, 2016 and initiated August 8, 2016. Recalling firm: Pharmatech LLC; Status: Terminated; Reported quantity: 1,008 bottles; Lot: Lot #: 20391519, Exp 11/17. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviations: Recall initiated as a precautionary measure due to a potential risk of product contamination with the bacteria B. cepacia.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Pharmatech LLC
- Distributor
- Nationwide
- Lot
- Lot #: 20391519, Exp 11/17
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDARugby FER Iron Liquid 50 mL UPC 00536-0710-80January 31, 2018
- FDALeader Liquid Vitamin D Supplement for Breastfed Infants 400 IU 50 mL UPC 096295128628January 31, 2018
- FDALeader Liquid Multivitamin Supplement for Infants and Toddlers 50 mL UPC 096295128611January 31, 2018
- FDAMajor Poly-Vita Drops 50 mL UPC 00904-5099-50January 31, 2018
- FDALamotrigine Tablets, USP, 150 mg, 500-count Tablets per bottle, Rx only, Manufactured by: Unichem LaboratoriesOctober 5, 2016
- FDANinjacof (chlophedianol HCl and pyrilamine maleate) Liquid, 12.5 mg/12.5 mg in each 5 mL, 16 fl oz (473 mL)October 5, 2016
Questions about this recall
Was Sennazon (sennosides) Syrup, 8.8 mg, 8 fl. oz. (237 mL) bottle, Mfd. for: Bayshore Pharmaceuticals, Tampla, FL 33619, NDC 76518-100-08. recalled?
Yes. FDA published recall D-1520-2016 on October 5, 2016. Reported hazard: CGMP Deviations: Recall initiated as a precautionary measure due to a potential risk of product contamination with the bacteria B. cepacia.
What should I do if I have this product?
Voluntary: Firm initiated · Letter